Neuroendocrine Tumor Research Foundation

Analysis

Neuroendocrine Tumor Research Foundation is a registered charity in United States, based in Quincy, MA. It received its IRS tax-exemption ruling in March 2005, 21 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Neuroendocrine Tumor Research Foundation reported income of $3.2m and spending of $3.6m, spending 112% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $5.2m to $3.2m (-39%), an average of -12% a year. The sharpest change came in the year to December 2021, when income rose by 76%. Over the whole period it spent 92% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Neuroendocrine Tumor Research Foundation sits at the 76th percentile: it is larger than about 76% of them. Against every charity in United States with reported income it ranks in the 89th percentile, and in the 88th percentile within MA. Charities of a similar size with the same main cause include Mha Health Foundation ($3.2m), Special Kids Inc ($3.2m) and Cray Medical Research Foundation ($3.2m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 80% of the total. Compensation of current officers, directors and key employees was $197k (5.5% of expenses). Other salaries and wages came to $718k. At year end it held assets of $20.6m against liabilities of $5.1m, net assets of $15.5m. It reported 8 employees.